Overall, our data reveal a novel mechanism for epigenetically upregulated PLCE1 in driving angiogenesis and proliferation in ESCC by activating the NF-κB signaling pathway, and suggest that modulation of PLCE1 may provide a therapeutic approach for combating ESCC. Here, NFKB1 is linked to esophageal squamous cell carcinoma.